TBX15 rs98422, DNM3 rs1011731, RAD51B rs8017304, and rs2588809 Gene Polymorphisms and Associations With Pituitary Adenoma.

Autor:	JuknytĖ G; Medical Academy, Lithuanian University of Health Sciences, Kaunas, Lithuania., LaurinaitytĖ I; Medical Academy, Lithuanian University of Health Sciences, Kaunas, Lithuania., VilkeviČiŪtĖ A; Neuroscience Institute, Medical Academy, Lithuanian University of Health Sciences, Kaunas, Lithuania alvita.vilkeviciute@lsmuni.lt., GedvilaitĖ G; Neuroscience Institute, Medical Academy, Lithuanian University of Health Sciences, Kaunas, Lithuania., GlebauskienĖ B; Neuroscience Institute, Medical Academy, Lithuanian University of Health Sciences, Kaunas, Lithuania., KriauČiŪnienĖ L; Neuroscience Institute, Medical Academy, Lithuanian University of Health Sciences, Kaunas, Lithuania., LiutkeviČienĖ R; Neuroscience Institute, Medical Academy, Lithuanian University of Health Sciences, Kaunas, Lithuania.
Jazyk:	angličtina
Zdroj:	In vivo (Athens, Greece) [In Vivo] 2021 Mar-Apr; Vol. 35 (2), pp. 815-826.
DOI:	10.21873/invivo.12322
Abstrakt:	Background: Pituitary adenoma (PA) is a benign tumor of parenchymal cells in the adenohypophysis, and it's development is strongly associated with genetic factors.This study aim was to find whether TBX15 rs98422, DNM3 rs1011731, RAD51B rs8017304, and rs2588809 single nucleotide polymorphisms can be associated with pituitary adenoma. While the TBX15 gene belongs to the T-box family of genes and is a transcription factor involved in many developmental processes, the DNM3 encodes a protein that is a member of the dynamin family with mechanochemical properties involved in actin-membrane processes, predominantly in membrane budding, and the RAD51B gene plays a significant role in homologous recombination in DNA repair for genome stability. Materials and Methods: The study enrolled 113 patients with pituitary adenoma and 283 healthy control subjects. DNA samples were extracted and purified from peripheral blood leukocytes. Genotyping was carried out using real-time polymerase chain reaction. The results were assessed using binomial logistic regression. Results: Our study revealed that RAD51B rs2588809 TT genotype could be associated with PA development in the co-dominant (OR=6.833; 95% CI=2.557-18.262; p<0.001) and recessive (OR=7.066; 95% CI=2.667-18.722; p<0.001) models. The same results were observed in females but not in males and PA without recurrence, while in PA with recurrence, no statistically significant results were obtained. Conclusion: RAD51B rs2588809 TT genotype may increase the odds of PA development in women; it may also be associated with non-recurrent PA development. (Copyright© 2021, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu